rituximab,blinatumomab
amgen,astellas
['leukemia', 'kudos', 'blinatumomab', 'ritux', 'leusm']
#ash22 #leusm kudos!!! to dr. litzow and team for this randomized study and practice changing!! it is not easy the study reach primary endpoint for os advantage!! 
Assistant Professor @MayoCancerCare @MayoClinic Alumni @MDAndersonNews. Interest in Acute Leukemia and Chronic myeloid disorders. Views are my own